These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20644324)

  • 1. New Delhi metallo-beta-lactamases: a wake-up call for microbiologists.
    Krishna BV
    Indian J Med Microbiol; 2010; 28(3):265-6. PubMed ID: 20644324
    [No Abstract]   [Full Text] [Related]  

  • 2. An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis.
    Pappas G
    Clin Microbiol Infect; 2011 Jun; 17(6):797-8. PubMed ID: 21463398
    [No Abstract]   [Full Text] [Related]  

  • 3. New Delhi metallo-beta-lactamase: a cautionary tale.
    Muir A; Weinbren MJ
    J Hosp Infect; 2010 Jul; 75(3):239-40. PubMed ID: 20435372
    [No Abstract]   [Full Text] [Related]  

  • 4. Omission of extended spectrum β lactamases detection: are the new Clinical Laboratory Standards Institute guidelines misleading?
    Chande C; Makhija S; Lilani S; Shirpurkar R; Veer P; Chivate A; Patekar P; Joshi A
    Indian J Med Microbiol; 2011; 29(4):443-4. PubMed ID: 22120816
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metallo-beta-lactamase producing bacteria].
    Takemura H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():453-6. PubMed ID: 17455661
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 7. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ESBL's: increase is alarming, but no reason to panic].
    Haneveld JK
    Tijdschr Diergeneeskd; 2010 Jun; 135(12):498-9. PubMed ID: 20608448
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
    Bennett JW; Mende K; Herrera ML; Yu X; Lewis JS; Wickes BL; Jorgensen JH; Murray CK
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):445-8. PubMed ID: 20226336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.
    Fisher JF; Meroueh SO; Mobashery S
    Chem Rev; 2005 Feb; 105(2):395-424. PubMed ID: 15700950
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
    Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
    [No Abstract]   [Full Text] [Related]  

  • 13. The incidence of beta-lactamase-producing pathogens.
    Acar JF; Kitzis MD; Gutmann L
    APMIS Suppl; 1989; 5():2-8. PubMed ID: 2660867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-lactamases...until when?].
    Dorobăţ C; Dorobăţ G; Manciuc C; Vâţă A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):647-55. PubMed ID: 22046767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China.
    Wang CX; Mi ZH
    J Antimicrob Chemother; 2004 Dec; 54(6):1159-60. PubMed ID: 15537691
    [No Abstract]   [Full Text] [Related]  

  • 17. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors.
    Coleman K
    Curr Opin Microbiol; 2011 Oct; 14(5):550-5. PubMed ID: 21840248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM
    Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of broad-spectrum beta-lactamases and experience with their identification in microbiological practice].
    Kolár M
    Klin Mikrobiol Infekc Lek; 2007 Oct; 13(5):195-205. PubMed ID: 17987569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.